Antiviral Activity of Nanomaterials against Coronaviruses.
Wali MuhammadZihe ZhaiChangyou GaoPublished in: Macromolecular bioscience (2020)
One of the challenges facing by world nowadays is the generation of new pathogens that cause public health issues. Coronavirus (CoV) is one of the severe pathogens that possess the RNA (ribonucleic acid) envelop, and extensively infect humans, birds, and other mammals. The novel strain "SARS-CoV-2" (severe acute respiratory syndrome coronavirus-2) causes deadly infection all over the world and presents a pandemic situation nowadays. The SARS-CoV-2 has 40 different strains that create a worrying situation for health authorities. The virus develops serious pneumonia in infected persons and causes severe damage to the lungs. There is no vaccine available for this virus up to present. To cure this type of infections by making vaccines and antiviral drugs is still a major challenge for researchers. Nanotechnology covering a multidisciplinary field may find the solution to this lethal infection. The interaction of nanomaterials and microorganisms is considered as a potential treatment method because the nanomaterials owe unique physicochemical properties. The aim of this review is to present an overview of previous and recent studies of nanomaterials against coronaviruses and to provide possible new strategies for upcoming research using the nanotechnology platform.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- public health
- gram negative
- early onset
- healthcare
- escherichia coli
- multidrug resistant
- mental health
- antimicrobial resistance
- drug induced
- human health
- coronavirus disease
- high throughput
- global health
- health information
- climate change
- quality improvement
- combination therapy
- acute respiratory distress syndrome
- social media